Stockscreener 앱 받기
1.02
0.00%
0.00
시간 외 거래:
1.02
전일 마감가:
$1.02
열려 있는:
$1.02
하루 거래량:
28,623
Relative Volume:
0.31
시가총액:
$61.02M
수익:
-
순이익/손실:
$-25.65M
주가수익비율:
-2.0816
EPS:
-0.49
순현금흐름:
$-24.59M
1주 성능:
-0.97%
1개월 성능:
-6.42%
6개월 성능:
-20.93%
1년 성능:
-38.92%
1일 변동 폭
$1.01
$1.03
1주일 범위
$1.01
$1.08
52주 변동 폭
$0.9054
$2.09
Vivani Medical Inc Stock (VANI) Company Profile
명칭
Vivani Medical Inc
전화
818-833-5000
주소
1350 S. LOOP ROAD, ALAMEDA
VANI을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
VANI
Vivani Medical Inc
|
1.02 | 61.02M | 0 | -25.65M | -24.59M | -0.49 |
|
VRTX
Vertex Pharmaceuticals Inc
|
490.47 | 128.67B | 11.02B | -535.60M | -978.00M | -2.20 |
|
REGN
Regeneron Pharmaceuticals Inc
|
585.49 | 60.99B | 14.20B | 4.41B | 3.54B | 38.28 |
|
ARGX
Argen X Se Adr
|
599.87 | 36.96B | 2.19B | 833.04M | -1.28B | 12.71 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
236.75 | 29.89B | 2.25B | -278.16M | -42.59M | -2.17 |
|
ONC
Beigene Ltd Adr
|
252.77 | 25.74B | 3.81B | -644.79M | -669.77M | -6.24 |
Vivani Medical Inc 주식(VANI)의 최신 뉴스
Vivani Medical Advances Drug Delivery Innovation with NanoPortal Technology - morgannewspaper.com
Vivani Medical's (VANI) Buy Rating Reiterated at HC Wainwright - MarketBeat
Short Interest in Vivani Medical, Inc. (NASDAQ:VANI) Increases By 32.2% - MarketBeat
Head-To-Head Comparison: Nexeon Medsystems (OTCMKTS:NXNN) and Vivani Medical (NASDAQ:VANI) - Defense World
Vivani Medical’s (VANI) “Buy” Rating Reiterated at HC Wainwright - Defense World
Vivani Medical to Participate in Virtual Fireside Chat Hosted by H.C. Wainwright & Company - GlobeNewswire
Vivani Medical expands partnership with Okava for dog therapy By Investing.com - Investing.com South Africa
Vivani Medical And Okava Expand Collaboration To Develop Okv-119 For Dogs, Targeting Metabolic Health And Longevity - marketscreener.com
Vivani Medical expands partnership with Okava for dog therapy - Investing.com
Vivani Medical and Okava Expand Collaboration to Develop - GlobeNewswire
Vivani Medical and Okava Expand Collaboration to Develop OKV-119 for Dogs, Targeting Metabolic Health and Longevity - Yahoo Finance
EXCLUSIVE: Vivani Medical Collaborates With Okava To Expand Development Of GLP-1 Therapy For Dogs - Yahoo Finance
Insider Buying: Vivani Medical, Inc. (NASDAQ:VANI) Director Buys 44,400 Shares of Stock - MarketBeat
Vivani medical director Gregg Williams invests $21,233 in shares By Investing.com - Investing.com Australia
Vivani medical director Gregg Williams buys $21,233 in stock By Investing.com - Investing.com South Africa
Vivani medical director Gregg Williams buys $21,233 in stock - Investing.com
Insider Buying: Vivani Medical, Inc. (NASDAQ:VANI) Director Buys 34,000 Shares of Stock - MarketBeat
HC Wainwright Reiterates "Buy" Rating for Vivani Medical (NASDAQ:VANI) - MarketBeat
Vivani Medical's director Gregg Williams acquires $205k in stock - Investing.com Australia
Vivani Medical’s director Gregg Williams acquires $205k in stock - Investing.com
Vivani Medical’s director Gregg Williams acquires $205k in stock By Investing.com - Investing.com South Africa
Vivani Medical's director Gregg Williams acquires $205k in stock By Investing.com - Investing.com India
Vivani Medical Director Gregg Williams Acquires Over 200K Shares - TradingView
Vivani Medical Announces Positive Preclinical Liver Fat Results with Miniature, Ultra Long-Acting GLP-1 Implant - MarketScreener
Vivani Medical (NASDAQ:VANI) Earns Buy Rating from HC Wainwright - Defense World
Vivani medical director Gregg Williams buys $24,959 in stock - Investing.com Australia
Vivani medical director Gregg Williams buys $24,959 in stock By Investing.com - Investing.com UK
Insider Purchases Worth US$5.02m See Losses As Vivani Medical Market Value Drops To US$60m - simplywall.st
H.C. Wainwright maintains Buy on Vivani Medical stock, $4 target By Investing.com - Investing.com Canada
H.C. Wainwright maintains Buy on Vivani Medical stock, $4 target - Investing.com
Vivani Medical (NASDAQ:VANI) Posts Earnings Results, Misses Expectations By $0.01 EPS - MarketBeat
Vivani medical chief business officer purchases $4,100 in shares By Investing.com - Investing.com South Africa
Vivani medical chief business officer purchases $4,100 in shares - Investing.com India
Vivani Medical’s Strategic Positioning and Promising Developments Earn a Buy Rating Despite Price Target Reduction - TipRanks
Vivani Medical: Q4 Earnings Snapshot - CT Insider
Vivani Medical Reports 2024 Financial Results and Business Progress - TipRanks
Vivani Medical Inc. (VANI) reports earnings - Quartz
Vivani Medical Advances with Successful Milestones in 2024 - TipRanks
Vivani Medical, Inc. SEC 10-K Report - TradingView
Vivani Medical Provides Business Update and Reports Fourth Quarter and Full Year 2024 Financial Results - GlobeNewswire
HC Wainwright Reaffirms Buy Rating for Vivani Medical (NASDAQ:VANI) - MarketBeat
Vivani Medical Inc (VANI) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.00%
자본화:
|
볼륨(24시간):